{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T14:29:22Z","timestamp":1786717762324,"version":"build-2736575974"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Ophthalmol"],"published-print":{"date-parts":[[2016]]},"DOI":"10.4103\/0301-4738.179727","type":"journal-article","created":{"date-parts":[[2016,4,5]],"date-time":"2016-04-05T06:14:11Z","timestamp":1459836851000},"page":"145","source":"Crossref","is-referenced-by-count":54,"title":["Systematic approach to managing vernal keratoconjunctivitis in clinical practice: Severity grading system and a treatment algorithm"],"prefix":"10.4103","volume":"64","author":[{"given":"NikhilS","family":"Gokhale","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0301-4738.179727-1","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jaci.2004.10.042","article-title":"Allergic conjunctivitis: Update on pathophysiology and prospects for future treatment","author":"Ono","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"key-10.4103\/0301-4738.179727-2","doi-asserted-by":"crossref","first-page":"108","DOI":"10.5415\/apallergy.2011.1.3.108","article-title":"Ocular allergy in the Asia Pacific region","author":"Katelaris","year":"2011","journal-title":"Asia Pac Allergy"},{"key":"key-10.4103\/0301-4738.179727-3","doi-asserted-by":"crossref","first-page":"486","DOI":"10.4103\/0301-4738.119431","article-title":"Demographic and clinical profile of vernal keratoconjunctivitis at a tertiary eye care center in India","author":"Saboo","year":"2013","journal-title":"Indian J Ophthalmol","ISSN":"https:\/\/id.crossref.org\/issn\/0301-4738","issn-type":"print"},{"key":"key-10.4103\/0301-4738.179727-4","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.ophtha.2009.11.043","article-title":"Tailored approach to the treatment of vernal keratoconjunctivitis","author":"Sacchetti","year":"2010","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.179727-5","doi-asserted-by":"crossref","first-page":"220","DOI":"10.4103\/0301-4738.95878","article-title":"Oral cyclosporine therapy for refractory severe vernal keratoconjunctivitis","author":"Gokhale","year":"2012","journal-title":"Indian J Ophthalmol","ISSN":"https:\/\/id.crossref.org\/issn\/0301-4738","issn-type":"print"},{"key":"key-10.4103\/0301-4738.179727-6","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1517\/14712598.5.12.1603","article-title":"Omalizumab: A future innovation for treatment of severe ocular allergy?","author":"Williams","year":"2005","journal-title":"Expert Opin Biol Ther"},{"key":"key-10.4103\/0301-4738.179727-7","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1136\/bjo.2009.165548","article-title":"Intravenous immunoglobulin (IVIg) in the management of severe refractory vernal keratoconjunctivitis","author":"Derriman","year":"2010","journal-title":"Br J Ophthalmol"},{"key":"key-10.4103\/0301-4738.179727-8","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1517\/14728214.10.3.505","article-title":"Emerging drugs for ocular allergy","author":"Leonardi","year":"2005","journal-title":"Expert Opin Emerg Drugs"},{"key":"key-10.4103\/0301-4738.179727-9","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1006\/exer.1998.0499","article-title":"Procollagens and inflammatory cytokine concentrations in tarsal and limbal vernal keratoconjunctivitis","author":"Leonardi","year":"1998","journal-title":"Exp Eye Res"},{"key":"key-10.4103\/0301-4738.179727-10","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/j.1399-3038.2009.00948.x","article-title":"Treatment of severe vernal keratoconjunctivitis with 1% topical cyclosporine in an Italian cohort of 197 children","author":"Tesse","year":"2010","journal-title":"Pediatr Allergy Immunol"},{"key":"key-10.4103\/0301-4738.179727-11","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s10384-008-0577-z","article-title":"Efficacy of topical cyclosporin A 0.05% in conjunctival impression cytology specimens and clinical findings of severe vernal keratoconjunctivitis in children","author":"Keklikci","year":"2008","journal-title":"Jpn J Ophthalmol"},{"key":"key-10.4103\/0301-4738.179727-12","doi-asserted-by":"crossref","first-page":"693","DOI":"10.3129\/i06-061","article-title":"Topical 2% cyclosporine A in preservative-free artificial tears for the treatment of vernal keratoconjunctivitis","author":"Kili\u00e7","year":"2006","journal-title":"Can J Ophthalmol"},{"key":"key-10.4103\/0301-4738.179727-13","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1177\/039463201002300322","article-title":"Long-term safety and efficacy of topical cyclosporine in 156 children with vernal keratoconjunctivitis","author":"Pucci","year":"2010","journal-title":"Int J Immunopathol Pharmacol"},{"key":"key-10.4103\/0301-4738.179727-14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/jop.1996.12.1","article-title":"Stability of cyclosporine 1% in artificial tears","author":"Fiscella","year":"1996","journal-title":"J Ocul Pharmacol Ther"},{"key":"key-10.4103\/0301-4738.179727-15","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/0167-5699(92)90111-J","article-title":"The mechanism of action of cyclosporin A and FK506","author":"Schreiber","year":"1992","journal-title":"Immunol Today"},{"key":"key-10.4103\/0301-4738.179727-16","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/01.ico.0000151507.49565.6e","article-title":"Topical tacrolimus ointment for treatment of refractory anterior segment inflammatory disorders","author":"Joseph","year":"2005","journal-title":"Cornea"},{"key":"key-10.4103\/0301-4738.179727-17","doi-asserted-by":"crossref","first-page":"S153","DOI":"10.1016\/j.jaci.2006.11.536","article-title":"Vernal Keratoconjunctivitis (VKC) treated with 0.1% FK-506 ophthalmic ointment: Result of three years follow-up","author":"Pacharn","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"key-10.4103\/0301-4738.179727-18","first-page":"177","article-title":"A double-masked comparison of 0.1% tacrolimus ointment and 2% cyclosporine eye drops in the treatment of vernal keratoconjunctivitis in children","author":"Labcharoenwongs","year":"2012","journal-title":"Asian Pac J Allergy Immunol"},{"key":"key-10.4103\/0301-4738.179727-19","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2165\/00002018-200831030-00001","article-title":"The US FDA 'black box' warning for topical calcineurin inhibitors: An ongoing controversy","author":"Ring","year":"2008","journal-title":"Drug Saf"}],"container-title":["Indian Journal of Ophthalmology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T13:28:01Z","timestamp":1786714081000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/0301-4738.179727"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016]]}},"alternative-id":["179727"],"URL":"https:\/\/doi.org\/10.4103\/0301-4738.179727","relation":{},"ISSN":["0301-4738"],"issn-type":[{"value":"0301-4738","type":"print"}],"subject":[],"published":{"date-parts":[[2016]]}}}